Publicaciones (29) Publicaciones de Almudena Ribed Sánchez

2023

  1. Analysis of the appropriateness of antibiotic prophylaxis in surgical procedures in Spain. Protocol for the “ProA-Q” study

    Farmacia Hospitalaria, Vol. 47, Núm. 5, pp. 224-229

  2. Engineering 3D-Printed Advanced Healthcare Materials for Periprosthetic Joint Infections

    Antibiotics, Vol. 12, Núm. 8

  3. Hacia la excelencia en la atención farmacéutica al paciente quirúrgico

    Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, Vol. 47, Núm. 1, pp. 26-30

2022

  1. Implementation of an enhanced recovery after surgery program including a patient school: Impact on quality of life results

    Injury, Vol. 53, Núm. 12, pp. 3987-3992

  2. Medication guide for the perioperative management of oral antineoplastic agents in cancer patients

    Expert Opinion on Drug Safety, Vol. 21, Núm. 1, pp. 107-119

2021

  1. Are we overdosing parenteral metamizole?

    Cirugia Espanola, Vol. 99, Núm. 1, pp. 68-70

2020

  1. Design of the functional requirements of a smartphone app for patients receiving oral antineoplastic agents: The e-OncoSalud® app

    Journal of Oncology Pharmacy Practice, Vol. 26, Núm. 1, pp. 105-115

  2. Effect of a Mobile App for the Pharmacotherapeutic Follow-Up of Patients with Cancer on Their Health Outcomes: Quasi-Experimental Study

    JMIR mHealth and uHealth, Vol. 8, Núm. 10

  3. Improving surgical antibiotic prophylaxis adherence and reducing hospital readmissions: A bundle of interventions including health information technologies

    European Journal of Hospital Pharmacy, Vol. 27, Núm. 4, pp. 237-242

  4. Novel mobile application for direct communication between pharmacists and patients treated with oral antineoplastic agents

    American Journal of Health-System Pharmacy, Vol. 77, Núm. 17, pp. 1393-1402

2019

  1. 3D printing designs and applications in a pharmacy department

    European Journal of Clinical Pharmacy, Vol. 21, Núm. 1, pp. 13-18

  2. Cancellations of elective surgical procedures due to inadequate management of chronic medications

    Journal of Clinical Pharmacy and Therapeutics, Vol. 44, Núm. 4, pp. 561-564

  3. Evolution of nutritional status and survival in patients with cancer on tyrosine kinase inhibitors treatment

    Endocrinologia, Diabetes y Nutricion, Vol. 66, Núm. 8, pp. 472-479

  4. Thromboprophylaxis Management in Surgical Patients: The Efficacy of a Protocol in the Electronic Prescription Program

    Quality management in health care, Vol. 28, Núm. 4, pp. 245-249

2017

  1. Improving pharmacotherapy outcomes in patients with hepatitis C virus infection treated with direct-acting antivirals: The GRUviC project

    International Journal of Clinical Practice, Vol. 71, Núm. 8

  2. Pharmacotherapy follow-up of key points in the safety of oral antineoplastic agents

    European Journal of Cancer Care, Vol. 26, Núm. 3

2016

  1. Effectiveness and Safety of Ombitasvir-Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin for HCV Genotype 1 Infection for 12 Weeks Under Routine Clinical Practice

    Annals of Pharmacotherapy, Vol. 50, Núm. 11, pp. 901-908

  2. Guiding pharmacist clinical interviews: A safety tool to support the education of patients treated with oral antineoplastic agents

    Expert Opinion on Drug Safety, Vol. 15, Núm. 4, pp. 427-435

  3. Pharmaceutical care program for onco-hematologic outpatients: safety, efficiency and patient satisfaction

    International Journal of Clinical Pharmacy, Vol. 38, Núm. 2, pp. 280-288

  4. Smartphone applications for cancer patients; what we know about them?

    Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, Vol. 40, Núm. 1, pp. 25-35